Detalhe da pesquisa
1.
Genome-wide meta-analysis for Alzheimer's disease cerebrospinal fluid biomarkers.
Acta Neuropathol;
144(5): 821-842, 2022 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36066633
2.
Cerebrospinal fluid proteomics in patients with Alzheimer's disease reveals five molecular subtypes with distinct genetic risk profiles.
Nat Aging;
4(1): 33-47, 2024 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38195725
3.
Grey matter network markers identify individuals with prodromal Alzheimer's disease who will show rapid clinical decline.
Brain Commun;
4(2): fcac026, 2022.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35310828